A type of composite material where the matrix material and additive are held together by covalently or non-covalently bound ligands is described. A particularly useful composite material covered by the present invention is a carbon nanotube-reinforced composite material where the matrix consists of a polymer, covalently attached to a linker, where said linker is non-covalently attached to the carbon nanotube. Methods for the preparation of such composite materials are provided.

The invention relates to a printed hemostatic product having at least three-dimensions and being made of a stack of layers deposited on one another from a first external layer up to a second external layer, wherein adjacent layers of the stack of layers are joined together, and wherein at least one layer of the stack of layers has at least one portion made from an hemostatic flowable with a composition comprising: non-cross-linked collagen of the fibrillar type comprising a content of fibrous collagen and/or fibrillar collagen of at least 70% by weight relative to the total weight of the collagen; and—at least one monosaccharide. The invention also relates to a method for forming such an hemostatic product with a three-dimensional additive printer, and the use of an hemostatic flowable as a printing ink in such a three-dimensional additive printer.

The invention relates to a printed hemostatic product having at least three-dimensions and being made of a stack of layers deposited on one another from a first external layer up to a second external layer, wherein adjacent layers of the stack of layers are joined together, and wherein at least one layer of the stack of layers has at least one portion made from an hemostatic flowable with a composition comprising: non-cross-linked collagen of the fibrillar type comprising a content of fibrous collagen and/or fibrillar collagen of at least 70% by weight relative to the total weight of the collagen; and—at least one monosaccharide. The invention also relates to a method for forming such an hemostatic product with a three-dimensional additive printer, and the use of an hemostatic flowable as a printing ink in such a three-dimensional additive printer.

The present disclosure provides biologically-based ink compositions, methods of making the biologically-based ink composition, as well as articles, objects, devices, and/or apparatuses fabricated from or that comprise the biologically-based ink compositions. The biologically-based ink composition can include a silk fibroin solution having a concentration of silk fibroin between 0.1 wt % and 10 wt %, as well as a thickening agent and a humectant dispersed throughout the silk fibroin solution. The biologically-based ink compositions may be used to functionalize a substrate to fabricate sensors, non-toxic conductive inks/textiles, microfluidic channels, technical apparel or fashion accessories, functionalized furniture, tensile canopies, architectural wall paper, facade components, or may be patterned on a substrate to encapsulate scents, flavors, dyes and pigments, therapeutic agents, or biologically active molecules.

The present disclosure provides biologically-based ink compositions, methods of making the biologically-based ink composition, as well as articles, objects, devices, and/or apparatuses fabricated from or that comprise the biologically-based ink compositions. The biologically-based ink composition can include a silk fibroin solution having a concentration of silk fibroin between 0.1 wt % and 10 wt %, as well as a thickening agent and a humectant dispersed throughout the silk fibroin solution. The biologically-based ink compositions may be used to functionalize a substrate to fabricate sensors, non-toxic conductive inks/textiles, microfluidic channels, technical apparel or fashion accessories, functionalized furniture, tensile canopies, architectural wall paper, facade components, or may be patterned on a substrate to encapsulate scents, flavors, dyes and pigments, therapeutic agents, or biologically active molecules.

Disclosed herein are engineered bacteria that manufacture biofilms from bacterial amyloid structures. These biofilms and biofilm matrices are capable of generating fibrous proteinaceous networks and being used as 3D-printing inks.

Disclosed herein are engineered bacteria that manufacture biofilms from bacterial amyloid structures. These biofilms and biofilm matrices are capable of generating fibrous proteinaceous networks and being used as 3D-printing inks.

Described is a biomaterial/carbonate-based ink that comprises a biopolymer-based mixture and bioceramics. The photo- and ionic crosslinkable biopolymer mixture comprises polysaccharide and gelatin-based materials. The bioceramics comprises an apatite and a carbonate. The biopolymer-based mixture is mixed with the bioceramics to form the ink. The ink is capable of being applied under wet or dry conditions. The wet condition is seawater or water or other aqueous solution. The ink is capable to instantly get solidified, when UV or blue light is applied in the presence of the ionic components found in seawater. After photo- or ionic crosslinking, this ink is stable for months.

Described is a biomaterial/carbonate-based ink that comprises a biopolymer-based mixture and bioceramics. The photo- and ionic crosslinkable biopolymer mixture comprises polysaccharide and gelatin-based materials. The bioceramics comprises an apatite and a carbonate. The biopolymer-based mixture is mixed with the bioceramics to form the ink. The ink is capable of being applied under wet or dry conditions. The wet condition is seawater or water or other aqueous solution. The ink is capable to instantly get solidified, when UV or blue light is applied in the presence of the ionic components found in seawater. After photo- or ionic crosslinking, this ink is stable for months.

Rheology modifiers comprising cross-linked poly(amino acid) and methods of their use in aqueous compositions. The modifiers comprise cross-linked poly(amino acid) microparticles having a mean equivalent diameter when fully swollen in deionized water of up to 1000 m, as measured by laser diffraction. In particular, the poly(amino acid) is D-, L- or D,L-Y-poly(glutamic acid). A method of preparing the modifier comprises cross-linking a poly(amino acid), drying the cross-linked poly(amino acid) and grinding the cross-linked poly(amino acid) to have the required diameter.